Precision BioSciences, Inc. (DTIL)

Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	98.75	116.68	189.58	143.66	89.8	180.89
Cash & Short-Term Investments	101.2	116.68	189.58	143.66	89.8	180.89
Cash Growth	-17.20%	-38.45%	31.96%	59.98%	-50.36%	75.29%
Accounts Receivable	1.55	0.9	0.72	0.49	10	0.97
Receivables	1.55	12.8	0.72	0.49	10	0.97
Prepaid Expenses	7.11	5.98	6.03	17.43	5.76	9.5
Other Current Assets	0.66	0.91	2.78	0.17	0	2.32
Total Current Assets	110.52	136.36	199.11	161.75	105.56	193.67
Property, Plant & Equipment	10.96	14.6	13.78	29.33	41.5	39.57
Long-Term Investments	3.21	3.21	4.75	6.84	-	-
Other Intangible Assets	0.39	0.4	0.73	2.05	1.37	1.43
Other Long-Term Assets	22.8	0.23	12.57	4.64	1.72	0.56
Total Assets	153.26	159.78	238.17	211.5	150.16	235.23
Accounts Payable	0.96	2.97	0.65	1.14	0.79	2.04
Accrued Expenses	6.89	6.54	6.93	10.79	9.01	6.83
Short-Term Debt	-	22.41	-	-	-	-
Current Portion of Leases	1.28	1.13	1.68	1.82	1.93	-
Current Unearned Revenue	0.18	12.04	46.19	21.24	30.24	16.49
Other Current Liabilities	2.69	4.9	4.21	0.98	0.85	1.58
Total Current Liabilities	11.98	49.99	59.66	35.98	42.83	26.93
Long-Term Debt	22.28	-	22.22	2.48	-	-
Long-Term Leases	6.75	7.72	1.06	4.81	8.59	-
Long-Term Unearned Revenue	36.58	83.08	92.87	77.02	53.93	65.9
Other Long-Term Liabilities	10.8	0.13	1.92	0.04	0.39	4.09
Total Liabilities	88.39	140.92	177.74	120.33	105.73	96.92
Common Stock	0	0	0	-	-	-
Additional Paid-In Capital	530.54	509.44	489.7	408.8	331.45	316.33
Retained Earnings	-464.72	-489.63	-428.31	-316.68	-286.07	-177.07
Treasury Stock	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Total Common Equity	64.87	18.86	60.43	91.17	44.43	138.31
Shareholders' Equity	64.87	18.86	60.43	91.17	44.43	138.31
Total Liabilities & Equity	153.26	159.78	238.17	211.5	150.16	235.23
Total Debt	30.31	31.27	24.96	9.11	10.52	-
Net Cash (Debt)	70.9	85.41	164.62	134.55	79.28	180.89
Net Cash Growth	-27.93%	-48.12%	22.35%	69.72%	-56.17%	75.29%
Net Cash Per Share	9.48	22.23	56.19	68.78	45.71	129.23
Filing Date Shares Outstanding	7.67	6.92	3.71	2.03	1.9	1.71
Total Common Shares Outstanding	7.48	4.16	3.7	2.03	1.76	1.71
Working Capital	98.54	86.37	139.44	125.77	62.74	166.74
Book Value Per Share	8.67	4.53	16.34	44.91	25.29	81.11
Tangible Book Value	64.48	18.46	59.7	89.12	43.05	136.88
Tangible Book Value Per Share	8.62	4.43	16.14	43.90	24.51	80.27
Machinery	-	19.38	20.78	22.93	25.3	23.23
Construction In Progress	-	0.07	0.52	3.04	1.89	0.7
Leasehold Improvements	-	11.95	11.95	22.78	26.58	25.97

Source: S&P Capital IQ. Standard template. Financial Sources.